Erasca, Inc. (ERAS)
NASDAQ: ERAS · Real-Time Price · USD
2.420
-0.110 (-4.35%)
At close: Oct 17, 2025, 4:00 PM EDT
2.380
-0.040 (-1.65%)
After-hours: Oct 17, 2025, 5:21 PM EDT
Erasca Market Cap
Erasca has a market cap or net worth of $686.48 million as of October 17, 2025. Its market cap has decreased by -6.14% in one year.
Market Cap
686.48M
Enterprise Value
349.16M
1-Year Change
-6.14%
Ranking
Category
Stock Price
$2.42
Market Cap Chart
Since the IPO on July 16, 2021, Erasca's market cap has decreased from $1.86B to $686.48M, a decrease of -63.06%. That is a compound annual growth rate of -20.87%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 16, 2025 | 717.69M | 1.13% |
| Dec 31, 2024 | 709.65M | 121.27% |
| Dec 29, 2023 | 320.72M | -50.41% |
| Dec 30, 2022 | 646.73M | -65.76% |
| Dec 31, 2021 | 1.89B | 1.66% |
| Jul 16, 2021 | 1.86B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 745.96B |
| Johnson & Johnson | 462.45B |
| AbbVie | 399.88B |
| UnitedHealth Group | 324.77B |
| AstraZeneca | 262.65B |
| Novartis AG | 252.43B |
| Novo Nordisk | 251.88B |
| Abbott Laboratories | 224.69B |